ArticleOPEN ACCESS

Activation of group 2 innate lymphoid cells via TL1A/DR3: A Solution to corticosteroid resistance?

American Journal of Respiratory and Critical Care Medicine
DOI: 10.1164/rccm.202007-2658ED
3Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.
Get full text

Cite

CITATION STYLE

APA

Skevaki, C., & Weckmann, M. (2020, October 15). Activation of group 2 innate lymphoid cells via TL1A/DR3: A Solution to corticosteroid resistance? American Journal of Respiratory and Critical Care Medicine. American Thoracic Society. https://doi.org/10.1164/rccm.202007-2658ED

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free